Migraine Drugs Market Growing Fast During 2018-2025- Estimated By Top Key Players like Abbott Laboratories, Allergan, AstraZeneca, Johnson & Johnson, Pfizer Inc.

Migraine is a clinical condition associated with painful headaches and other symptoms such as nausea, sensitivity to smell, and others. These headaches generally occur on one side of the head and each episode of a migraine has different duration and intensity. Migraine drugs are employed in the treatment of headaches associated with a migraine.

A rise in the prevalence of a migraine drives the migraine drugs market. Moreover, the increase in the female population and a surge in awareness among patients related to the prevention and treatment of migraine are the key factors that augment the growth of the market.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr&utm_medium=ss

However, side effects associated with migraine drugs is a factor that hinders the market growth. On the contrary, the presence of growth opportunities in emerging nations is expected to provide new opportunities for key players.

According to a new report published by Allied Market Research, titled, " Migraine Drugs by Type, Route of Administration, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Major Players:

• Abbott Laboratories
• Allergan Plc.
• AstraZeneca
• Eisai Co.Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories
• Johnson & Johnson
• Merck & Co.
• Pfizer Inc.

Make an Inquiry for purchasing this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr&utm_medium=ss

The report segments the migraine drugs market based on type, route of administration, distribution channel, and region. Based on the type, the market is bifurcated into abortive medicine and preventive medicine. Depending on the route of administration, it is fragmented into oral, injection, and others. By distribution channel, it is categorized into hospital-based pharmacies, retail pharmacies, and online pharmacies.

Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Findings of the Migraine Drugs Market:

• North America occupied a two-fifths share of the global migraine drugs market.

• Oral is anticipated to grow with the highest CAGR throughout the forecast period.

• Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025.

• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA

Get a Special Discount on this Report @ https://www.alliedmarketresearch.com/checkout/824235?utm_source=openpr&utm_medium=ss

About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.